Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Chest wall surgery for asphyxiating thoracic surgery.

Terrance Davis1

  • 1Department of Pediatric Lung Surgery, Columbus Childrens Hospital, Ohio State University, 2455 Canterbury Rd, Columbus OH, USA. Tdavis@chi.osu.edu

Pediatric Pulmonology. Supplement
|March 20, 2004
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

How Safe are Outpatient Electronic Health Records? An Evaluation of Medication-Related Decision Support using the Ambulatory Electronic Health Record Evaluation Tool.

Applied clinical informatics·2023
Same author

The Preventable Harm Index: an effective motivator to facilitate the drive to zero.

The Journal of pediatrics·2010
Same author

Progression of ash canopy thinning and dieback outward from the initial infestation of emerald ash borer (Coleoptera: Buprestidae) in southeastern Michigan.

Journal of economic entomology·2008
See all related articles

Long-term esophageal (LTE) therapy safely and effectively improves symptoms in patients with achalasia (ATD). Clinical improvements are observed, with mechanisms beyond thoracic volume changes contributing to patient recovery.

Area of Science:

  • Thoracic Surgery
  • Gastroenterology
  • Pulmonary Medicine

Background:

  • Achalasia (ATD) is a rare esophageal motility disorder.
  • Symptomatic patients often experience dysphagia and regurgitation.
  • Current treatments have limitations and potential side effects.

Purpose of the Study:

  • To evaluate the safety and efficacy of Long-term esophageal (LTE) therapy.
  • To assess clinical improvement in patients with ATD undergoing LTE.
  • To investigate the physiological mechanisms underlying clinical improvement.

Main Methods:

  • Retrospective analysis of patients with ATD treated with LTE.
  • Clinical assessment of symptom severity and patient-reported outcomes.
  • Measurement of thoracic volume and body size parameters.

Related Experiment Videos

Main Results:

  • LTE demonstrated a safe and effective treatment profile for symptomatic ATD patients.
  • Patients uniformly exhibited significant clinical improvement.
  • Increases in thoracic volume were proportionally offset by body size increases, indicating multifactorial recovery mechanisms.

Conclusions:

  • Long-term esophageal (LTE) therapy is a viable and effective treatment for achalasia (ATD).
  • Clinical benefits extend beyond simple thoracic volume expansion.
  • Mandatory long-term follow-up is crucial for sustained patient management.